Also known as: Kenvue
Kenvue is an American consumer health company spun out of Johnson & Johnson's consumer health division. It is headquartered in Summit, New Jersey and markets major brands including Tylenol, Neutrogena, Listerine, and Band-Aid.
Johnson & Johnson said revenue could reach about $100.5 billion at the midpoint in 2026 after 2024 net sales rose 6% to $94.2 billion. The company faces talc litigation, Stelara patent losses and U.S. drug price negotiations.
Johnson & Johnson announced a more than $1 billion investment in a next generation cell therapy manufacturing facility in Montgomery County, Pennsylvania, part of the company's $55 billion U.S. investment strategy through early 2029.
